Application 210575
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 150MG BASE | No | No |
| 002 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 200MG BASE | No | No |
| 003 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 300MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210575-001 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | ||
| A210575-002 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | ||
| A210575-003 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210575-002 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2020-06-04 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210575-003 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2020-06-04 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210575-001 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2020-06-04 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2020-11-12 02:37 UTC | 2020-11 | A210575-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A210575-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A210575-003 | AB | 1 | c0c555d07b60… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atazanavir Sulfate | ATAZANAVIR | Aurobindo Pharma Limited | 7fbea274-d6b5-4faa-bbf0-05fefab42114 | 2025-08-06 | Warnings, Adverse reactions | Atazanavir Sulfate |
| Atazanavir Sulfate | ATAZANAVIR SULFATE | Teva Pharmaceuticals USA, Inc. | 654b7e08-33d8-47e7-b37f-3681e79c7b8b | 2024-12-30 | Warnings, Adverse reactions | Atazanavir Sulfate ATAZANAVIR SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70710-1050 | ATAZANAVIR | ATAZANAVIR | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1050 | ATAZANAVIR | ATAZANAVIR | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70710-1051 | ATAZANAVIR | ATAZANAVIR | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1051 | ATAZANAVIR | ATAZANAVIR | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70710-1052 | ATAZANAVIR | ATAZANAVIR | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1052 | ATAZANAVIR | ATAZANAVIR | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70771-1591 | ATAZANAVIR | ATAZANAVIR | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1591 | ATAZANAVIR | ATAZANAVIR | Cadila Healthcare Limited | ANDA | Current |
| 70771-1592 | ATAZANAVIR | ATAZANAVIR | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1592 | ATAZANAVIR | ATAZANAVIR | Cadila Healthcare Limited | ANDA | Current |
| 70771-1593 | ATAZANAVIR | ATAZANAVIR | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1593 | ATAZANAVIR | ATAZANAVIR | Cadila Healthcare Limited | ANDA | Current |